MEDIROM MOTHER Labs and NFES Technologies have entered into a capital and business alliance. As part of this partnership, the NFES Group has been selected as the lead investor in a Series A funding round, which is valued at 9 billion yen. For more detailed information, please refer to the attached PDF.